Artificial oocyte activation
AssigneeThe Curators of the University of Missouri
InventorsKiho Lee, Randall S. Prather
Life of this patent
Estimating the term…
Abstract
The present invention provides novel methods for improving the efficiency of artificial activation of unfertilized mammalian oocytes by reducing the intracellular concentration of Zn2+ in the oocyte. The methods of the invention may additionally comprise a preceding step of increasing the intracellular concentration of Ca2+ in the oocyte prior to reduction of the intracellular Zn2+ concentration. The invention further provides unfertilized oocytes activated by the disclosed methods and viable mammalian animals produced from unfertilized oocytes activated by the disclosed methods.
Claims41
A method of activating an unfertilized livestock or domestic mammalian oocyte comprising decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety.
A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 0.1 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 200 μM for a period of time comprising approximately 30 minutes.
A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 1.0 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 5 μM for a period of time comprising approximately 30 minutes.
A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 1.0 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 10 μM for a period of time comprising approximately 30 minutes.
Dependencies are inferred from the claim text.